SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (402)10/24/1997 3:35:00 PM
From: dbuki  Read Replies (1) of 1972
 
GeneMedicine's recent Patent No.5,676,954 seems to conflict with Vical Patent No.5,459,127 "Use of Cationic Lipids to Deliver Genes In Vivo", issued in 1995. This conflict would only involve the Leuvectin/Allovectin cancer effort where Vical is using lipid molecules (cytofectins) for delivery. It has no bearing on Vical's all important naked DNA vaccines.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News